TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -2 | -22 | -22 | -49 | -71 | -82 | -41 |
| S | %wins | 67 | 67 | 67 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/15 18:21 | 6/10/15 | AAVL | Avalanche Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chalberg Thomas W. | CA | DO | CEO | S | -951 | 38.05 | 13 | -25 | -2 | 1,099 | D | -10 | 3 | 13 | 2 | 7 | -1 | 2 | -60 | -62 | -76 | -79 | |||
5/7/15 16:16 | 5/5/15 | AAVL | Avalanche Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chalberg Thomas W. | CA | DO | CEO | S | -750 | 30.00 | 11 | -25 | -2 | 1,124 | D | -7 | -1 | -19 | -21 | -6 | 1 | -2 | 8 | 22 | -54 | -71 | -84 | ||
1/15/15 16:58 | 1/13/15 | AAVL | Avalanche Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chalberg Thomas W. | CA | DO | CEO | S | -4,714 | 55.46 | 18 | -85 | -7 | 1,126 | D | 90 | 43 | 17 | -3 | -3 | -6 | -15 | -27 | -17 | -62 | -80 | |||
1/14/15 17:43 | 12/12/14 | AAVL | Avalanche Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chalberg Thomas W. | CA | DO | CEO | M.d | 0 | 0.2100 | 18 | 0 | 0 | 1,211 | M | 95 | 55 | 14 | 0 | 0 | -9 | -26 | -35 | -26 | -69 | -86 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |